Atlas Trials

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Clinical trial NCT01836679 · COMPLETED

Trial details

NCT number
NCT01836679
Sponsor
Chipscreen Biosciences, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small-cell Lung Cancer
Start date
2013-04-01
Primary completion
2015-05-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.